Cibc World Markets Corp Neogenomics Inc Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Neogenomics Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 28,293 shares of NEO stock, worth $201,729. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,293
Previous 11,932
137.12%
Holding current value
$201,729
Previous $196,000
36.73%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$140 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$102 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$47.9 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$43.1 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$40.9 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $897M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...